Skyler A. Briggs

Statistics

Publications

Citations

315

H-Index

Active since

2021

Affiliations

Janssen (United States)(Current)

AbbVie (United States)

Emulate (United States)

Harvard University

Boston Children's Hospital

Skyler A. Briggs is an author at Janssen (United States) specializing in hepatotoxicity prediction, hepatotoxicology, and preclinical drug development.

ORCID

Publications per year

2021–2022

Publications

Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology

Lorna Ewart, Skyler A. Briggs, Christopher V. Carman et al. · Communications Medicine · 2022 · 279 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

Qualifying a human Liver-Chip for predictive toxicology: Performance assessment and economic implications

Lorna Ewart, Skyler A. Briggs, Christopher V. Carman et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 36 citations · Full text

Pharmacy, Biotechnology, Toxicology +15

1–2 of 2